Houlihan Lokey Advises Autism in Motion Clinics, Inc.

Transaction: Houlihan Lokey Advises Autism in Motion Clinics, Inc.

Houlihan Lokey is pleased to announce that Autism in Motion Clinics, Inc. (AIM), a portfolio company of Breakout Capital, LLC, has been acquired by Hopebridge, LLC, a portfolio company of Arsenal Capital Partners. The transaction closed on October 15, 2021.

Founded in 2017 and based in Chicago, Illinois, AIM provides one-on-one, clinic-based applied behavior analysis (ABA) therapy to children with autism at more than 25 clinics across Alabama, Arkansas, North Carolina, Oklahoma, and Tennessee. AIM was founded to bring gold-standard ABA therapy to children in areas where the unmet need for services is highest.

AIM is a portfolio company of Chicago-based Breakout Capital, a growth equity firm that takes a thesis-driven approach to investing in companies primarily in the healthcare and consumer verticals. Breakout first backed AIM Clinics when the company operated a single clinic and continues to support the company.

Founded in 2005 and based in Indianapolis, Indiana, Hopebridge was started to serve the growing need for autism treatment services and to improve the lives of affected children and families. Hopebridge is committed to providing personalized outpatient ABA and occupational, speech, and feeding therapies for children touched by autism spectrum disorder and behavioral, physical, social, communication, and sensory challenges. Hopebridge continues to open state-of-the-art autism therapy centers in new communities to reach patients and families who need services.

Arsenal Capital Partners is a leading private equity firm that specializes in investments in middle-market industrial growth and healthcare companies. Since its inception in 2000, Arsenal has raised institutional equity investment funds of more than $10 billion, has completed more than 250 platform and add-on investments, and achieved more than 30 realizations.

Houlihan Lokey served as the exclusive financial advisor.

This transaction further strengthens and highlights Houlihan Lokey’s continued leadership position in multisite healthcare M&A. Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the world. In 2021, the group closed 43 transactions and was ranked the No. 1 M&A advisor for global healthcare transactions under $1 billion by Refinitiv.* Houlihan Lokey’s Healthcare Group has closed more than 350 M&A healthcare transactions since its inception.

*Excludes accounting firms and brokers.

View All Transactions